Intec Pharma Partners with LTS for Manufacture of Accordion Pill Carbidopa/Levodopa for Treatment of Parkinson’s Disease A global leader in formulation and film technology manufacture to establish commercial-scale production capabilities for Intec’s lead product candidate in FDA compliant facility JERUSALEM, March 12, 2018 /PRNewswire/ — Intec Pharma Ltd. (NASDAQ, TASE: NTEC) (“Intec” or the “Company”) today announces […]
CANNABIS BUZZ Pure play marijuana stocks are scarce. Most companies in the marijuana industry trade over the counter (OTC), where solid information regarding operations and financials is difficult to retrieve. Exceptions extend to issues such as GW Pharmaceuticals plc (NASDAQ: GWPH), a British biopharmaceutical company that developed two cannabis-based drugs licensed for use outside the United States. Sativex is used to treat muscular contractions in multiple sclerosis patients, and Epidiolex targets epileptic seizures in children. Both drugs have entered Phase 3 clinical stage trials in the United States. GWPH has a $2 billion market cap and had returned 23% year to date (YTD) as of Aug. 15, 2016.
Political and legal obstacles remain the highest hurdles for the marijuana industry in 2016. Four states, Oregon, Washington, Alaska and Colorado, have legalized recreational marijuana, and 25 states plus the District of Columbia have approved cannabis for medicinal purposes. The plant is categorized at the federal level as a Schedule 1 drug, possessing the highest risk for psychological and physical dependence, and more curiously, having no acceptable medical use.
TERRASCEND’S WHOLLY-OWNED SUBSIDIARY, SOLACE HEALTH INC. RECEIVES SALES LICENCE TO SELL DRIED CANNABIS NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, ONTARIO – March 9, 2018 – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) is pleased to announce that the Company’s wholly-owned subsidiary, Solace Health Inc. (“Solace Health”) has been granted […]
Isodiol International Inc. Provides Update on Biosynthesis Pharma Group Acquisition VANCOUVER, British Columbia, March 12, 2018 (GLOBE NEWSWIRE) — Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that the Company has successfully performed all of […]
Decriminalization of Cannabis Delayed Yet Again Decriminalization of Cannabis There’s another deferral of cannabis sanctioning. This time, it was a direct result of the Liberals’ inability to deal with the Senate.One of the Liberals’ key battle guarantees in 2015 was the decriminalization of cannabis. Off that guarantee, billions in securities exchange esteem have been made. […]
Invictus’ Acreage Pharms Receives Notification of Sales license Inspection VANCOUVER, – INVICTUS MD STRATEGIES CORP.’s (“Invictus” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS1) Acreage Pharms Ltd. (“Acreage Pharms“) is pleased to announce that it has received notification from Health Canada (HC) that its sales license inspection has been scheduled for later in March and […]